Black Diamond Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Black Diamond Therapeutics's estimated annual revenue is currently $7.9M per year.
- Black Diamond Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Black Diamond Therapeutics has 51 Employees.
- Black Diamond Therapeutics grew their employee count by -39% last year.
Black Diamond Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder, President and CEO | Reveal Email/Phone |
2 | Chief Business Officer and Chief Financial Officer | Reveal Email/Phone |
3 | Head Information Technology | Reveal Email/Phone |
4 | VP Finance | Reveal Email/Phone |
5 | VP, Legal & Intellectual Property | Reveal Email/Phone |
6 | Chief Operating Officer & General Counsel | Reveal Email/Phone |
7 | Sr Director, Head Data Management | Reveal Email/Phone |
8 | Chief Financial Officer | Reveal Email/Phone |
9 | Director Finance and Assistant Controller | Reveal Email/Phone |
10 | Associate Director | Reveal Email/Phone |
Black Diamond Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.7M | 82 | -45% | $107.3M | N/A |
#2 | $0.2M | 1 | -50% | N/A | N/A |
#3 | $6.2M | 40 | 21% | N/A | N/A |
#4 | $42.2M | 218 | 4% | $165M | N/A |
#5 | $14.6M | 94 | -37% | $312.8M | N/A |
#6 | $0.3M | 2 | -67% | N/A | N/A |
#7 | $235M | 366 | -5% | $340.9M | N/A |
#8 | $56M | 289 | -7% | $7.6M | N/A |
#9 | $4.7M | 61 | 36% | N/A | N/A |
#10 | $2M | 13 | 8% | N/A | N/A |
What Is Black Diamond Therapeutics?
Black Diamond Therapeutics Inc. is a leading venture-backed biotechnology company focused on the discovery and development of precision medicines for cancer that are directed against a novel class of allosteric mutant oncogenes.
keywords:N/A
N/A
Total Funding
51
Number of Employees
$7.9M
Revenue (est)
-39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Black Diamond Therapeutics News
Black Diamond Therapeutics, Inc., a Cambridge, Mass.-based precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, completed a Series C financing of $85m. The round was led by Boxer Capital of the Tavistock Group, with participat ...
Black Diamond Therapeutics, Inc., a Cambridge, Mass.-based biotechnology company developing next-generation precision medicines for cancer, completed an $85m Series B financing. The round was co-led by New Enterprise Associates and RA Capital Management, with participation from new investors Ne ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $35M | 51 | 13% | N/A |
#2 | $10.3M | 51 | -12% | N/A |
#3 | $6M | 51 | 19% | $176.5M |
#4 | $4.7M | 51 | -11% | N/A |
#5 | $6.2M | 51 | -4% | $4M |